Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001209191-20-039768

Director bought 1,250,000 shares at $8.00 ($10,000,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Booth Bruce Director 2020-06-29 Purchase +1,250,000 $8.00 $10,000,000 1,250,000 I
Open-market purchases · 1,250,000 sh · avg $8.00 · $10,000,000
Loading xslF345X03/doc4.xml…